Clinton Urges Plan B Decision, Says FDA Changed Standards “Midstream”
This article was originally published in The Pink Sheet Daily
Executive Summary
The lawmakers ask FDA to “expeditiously” reach a decision on the switch application in comments submitted to the agency.
You may also be interested in...
FDA Staff Accounts Conflict On Plan B Decision Timeline, GAO Report Finds
Office of New Drugs officials contend they were told the over-the-counter switch application for Barr's emergency contraceptive would be denied following a positive advisory committee review, but Center for Drug Evaluation & Research officials deny the decision was made before the letter was sent.
FDA Staff Accounts Conflict On Plan B Decision Timeline, GAO Report Finds
Office of New Drugs officials contend they were told the over-the-counter switch application for Barr's emergency contraceptive would be denied following a positive advisory committee review, but Center for Drug Evaluation & Research officials deny the decision was made before the letter was sent.
GAO Expected To Release Draft Plan B Investigation; Pro-Choice Caucus Urges OTC Approval
Sixty-two members of Congress write to Acting Commissioner von Eschenbach on the Plan B issue.